Details of the Drug Combinations

General Information of This Drug (ID: DMNPZL4)

Drug Name
Dacarbazine   DMNPZL4
Synonyms
Biocarbazin; Biocarbazine; DTIC; DTICDome; DTIE; Dacarbazino; Dacarbazinum; Dacatic; Decarbazine; Deticene; Dimethyltriazenoimidazolecarboxamide; ICDMT; ICDT; Biocarbazine R; DTIC Dome; Dimethyl Imidazole Carboxamide; Dimethyl Triazeno Imidazole Carboxamide; Imidazole carboxamide; HE1150000; Carboxamide (TN); Carboxamide, Dimethyl Imidazole; DIC (TN); DTIC (TN); DTIC-Dome; Dacarbazino [INN-Spanish]; Dacarbazinum [INN-Latin]; Imidazole (TN); Imidazole Carboxamide, Dimethyl; NPFAPI-05; DTIC-Dome (TN); Di-me-triazenoimidazolecarboxamide; Di-methyl-triazenoimidazolecarboxamide; Dtic-Dome (TN); DTIC, DTIC-Dome, Dacarbazine; Dacarbazine (JAN/USP/INN); Dacarbazine [USAN:INN:BAN:JAN]; (5E)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide; (5Z)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide; (Dimethyltriazeno)imidazolecarboxamide; 4(5)-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide; 4(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide; 4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide; 4-(3,3-Dimethyltriazeno)imidazole-5-carboxamide; 4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide; 4-(Dimethyltriazeno)imidazole-5-c arboxamide; 4-(Dimethyltriazeno)imidazole-5-carboxamide; 4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide; 4-[(1E)-3,3-Dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide; 4-[3,3-dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide; 5(or 4)-(dimethyltriazeno)imidazol e-4(or 5)-carboxamide; 5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide; 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide; 5-(3,3-Dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide; 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide; 5-(3,3-Dimethyltri azeno)imidazole-4-carboxamide; 5-(3,3-Dimethyltriazeno)-imidazole-4-carbamide; 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide; 5-(3,3-dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide; 5-(Dimethyltriazeno)-4-imidazolecarboxamide; 5-(Dimethyltriazeno)imidazole-4-carboxamide; 5-(Dimethyltriazeno)imidazole-4-carboximide; 5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide; 5-[3,3-Dimethyl-1-triazenyl]imidazole-4-carboxamide
Indication
Disease Entry ICD 11 Status REF
Adenocarcinoma 2D40 Approved [1]
Astrocytoma 2A00.0Y Approved [1]
Brain disease 8C70-8E61 Approved [1]
Central nervous system disease 8A04-8D87 Approved [1]
Glioblastoma 2A00 Approved [1]
Gliosarcoma N.A. Approved [1]
Melanoma 2C30 Approved [2]
Classic Hodgkin lymphoma N.A. Investigative [1]
Neuroblastoma 2D11.2 Investigative [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

680 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Dacarbazine DCCYU60 ABIRATERONE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
ABIRATERONE + Dacarbazine DCLIKY7 ABIRATERONE Astrocytoma (Cell Line: SNB-19) [3]
ABIRATERONE + Dacarbazine DCM24A9 ABIRATERONE Clear cell renal cell carcinoma (Cell Line: A498) [3]
ABIRATERONE + Dacarbazine DCN7VVP ABIRATERONE Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
ABIRATERONE + Dacarbazine DCE2TI4 ABIRATERONE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
ABIRATERONE + Dacarbazine DCHRAZM ABIRATERONE Glioma (Cell Line: SF-295) [3]
ABIRATERONE + Dacarbazine DCCARHZ ABIRATERONE Papillary renal cell carcinoma (Cell Line: ACHN) [3]
ABIRATERONE + Dacarbazine DCMAUHB ABIRATERONE Plasma cell myeloma (Cell Line: RPMI-8226) [3]
ABIRATERONE + Dacarbazine DCF214I ABIRATERONE Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Dacarbazine DCKVJ9J ABIRATERONE Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
ABIRATERONE + Dacarbazine DCTT1ES ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Dacarbazine DCT0MSE ABIRATERONE Melanoma (Cell Line: SK-MEL-2) [4]
Amonafide + Dacarbazine DC9FMER Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Amonafide + Dacarbazine DCJQETA Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Amonafide + Dacarbazine DCQLPXC Amonafide Glioma (Cell Line: SF-268) [3]
Amonafide + Dacarbazine DC0C4A2 Amonafide Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Dacarbazine DC90POZ Anastrozole Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Dacarbazine DC75U61 Anastrozole Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Dacarbazine DCCX41M Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Dacarbazine DCHGAXW Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Dacarbazine DCVZMEB Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Dacarbazine DC6FU5V Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Dacarbazine DCBI9HN Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Dacarbazine DCBWC5Y Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Dacarbazine DCAJZQ5 Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Dacarbazine DCLPLRW Anastrozole Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Dacarbazine DC06M8J Anastrozole Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Dacarbazine DC1LQBA Anastrozole Renal cell carcinoma (Cell Line: UO-31) [3]
Bleomycin + Dacarbazine DCXRE4P Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Dacarbazine DCFMEI7 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Dacarbazine DCV053A Bleomycin Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Dacarbazine DC6CNZU Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Dacarbazine DC0HMTN Bleomycin Glioma (Cell Line: SF-268) [3]
Bleomycin + Dacarbazine DCBJRY2 Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Dacarbazine DCFJ24H Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Dacarbazine DCFXNLI Bleomycin Renal cell carcinoma (Cell Line: SN12C) [3]
Bleomycin + Dacarbazine DCVB9ZJ Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Bleomycin + Dacarbazine DCZCOOE Bleomycin Carcinoma (Cell Line: RXF 393) [5]
Bleomycin + Dacarbazine DC4ZU6Y Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [5]
Bleomycin + Dacarbazine DC30TXJ Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Bleomycin + Dacarbazine DCUD2DO Bleomycin Adenocarcinoma (Cell Line: A549) [4]
Bleomycin + Dacarbazine DCGBORJ Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Bleomycin + Dacarbazine DCQA0NB Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Bleomycin + Dacarbazine DC81E7X Bleomycin Lung adenocarcinoma (Cell Line: EKVX) [4]
Bleomycin + Dacarbazine DCHMI6O Bleomycin Lung adenocarcinoma (Cell Line: HOP-62) [4]
Bleomycin + Dacarbazine DCGJXC5 Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [4]
Bleomycin + Dacarbazine DCKNDPY Bleomycin Melanoma (Cell Line: SK-MEL-2) [4]
Bleomycin + Dacarbazine DC2V3QY Bleomycin Melanoma (Cell Line: UACC-257) [4]
Cabazitaxel + Dacarbazine DCXGTCW Cabazitaxel Adenocarcinoma (Cell Line: DU-145) [3]
Cabazitaxel + Dacarbazine DC2S3IK Cabazitaxel Adenocarcinoma (Cell Line: A549) [3]
Cabazitaxel + Dacarbazine DCJYYSM Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [3]
Cabazitaxel + Dacarbazine DCTRNQX Cabazitaxel Adenocarcinoma (Cell Line: HCC-2998) [3]
Cabazitaxel + Dacarbazine DCM6OFW Cabazitaxel Adenocarcinoma (Cell Line: HT29) [3]
Cabazitaxel + Dacarbazine DCNP7RV Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Cabazitaxel + Dacarbazine DCR5F7O Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Cabazitaxel + Dacarbazine DCGBTQP Cabazitaxel Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Cabazitaxel + Dacarbazine DC417S5 Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Cabazitaxel + Dacarbazine DCYUI6W Cabazitaxel Astrocytoma (Cell Line: SNB-19) [3]
Cabazitaxel + Dacarbazine DC6XWML Cabazitaxel Clear cell renal cell carcinoma (Cell Line: A498) [3]
Cabazitaxel + Dacarbazine DCQB8ZJ Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Cabazitaxel + Dacarbazine DCOUMMF Cabazitaxel Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Cabazitaxel + Dacarbazine DCLIR66 Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Cabazitaxel + Dacarbazine DC44XUQ Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Cabazitaxel + Dacarbazine DCQGC8I Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Cabazitaxel + Dacarbazine DCM1NKR Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Cabazitaxel + Dacarbazine DCEN4IC Cabazitaxel Lung adenocarcinoma (Cell Line: HOP-62) [3]
Cabazitaxel + Dacarbazine DC1UO6U Cabazitaxel Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Cabazitaxel + Dacarbazine DC8JHPS Cabazitaxel Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Cabazitaxel + Dacarbazine DC69K05 Cabazitaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Cabazitaxel + Dacarbazine DCB02QZ Cabazitaxel Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Cabazitaxel + Dacarbazine DC2DRC2 Cabazitaxel Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Cabazitaxel + Dacarbazine DC1AUE3 Cabazitaxel Prostate carcinoma (Cell Line: PC-3) [3]
Cabazitaxel + Dacarbazine DCKC144 Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [3]
Cabazitaxel + Dacarbazine DCNKRT8 Cabazitaxel Carcinoma (Cell Line: RXF 393) [5]
Cabazitaxel + Dacarbazine DCCJJ4J Cabazitaxel Carcinoma (Cell Line: MCF7) [5]
Crizotinib + Dacarbazine DCL9M7T Crizotinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Crizotinib + Dacarbazine DCX5802 Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Crizotinib + Dacarbazine DCG1NJN Crizotinib Amelanotic melanoma (Cell Line: M14) [3]
Crizotinib + Dacarbazine DCB5I5M Crizotinib Astrocytoma (Cell Line: SNB-19) [3]
Crizotinib + Dacarbazine DCN4T17 Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Crizotinib + Dacarbazine DCH592U Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Crizotinib + Dacarbazine DCWVU4H Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Crizotinib + Dacarbazine DCUVBNZ Crizotinib Glioma (Cell Line: SF-295) [3]
Crizotinib + Dacarbazine DCG31HD Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Crizotinib + Dacarbazine DCL1Y10 Crizotinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Crizotinib + Dacarbazine DCNAPSN Crizotinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Crizotinib + Dacarbazine DC5MSU4 Crizotinib Melanoma (Cell Line: UACC-257) [3]
Crizotinib + Dacarbazine DCHQDY7 Crizotinib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Crizotinib + Dacarbazine DCH4C6T Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Crizotinib + Dacarbazine DCYVJ32 Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Crizotinib + Dacarbazine DCMJPZU Crizotinib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Crizotinib + Dacarbazine DC6H27Q Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Crizotinib + Dacarbazine DCFTGI3 Crizotinib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Dacarbazine + Mechlorethamine DCGI0SS Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Mechlorethamine DCO2557 Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Dacarbazine + Pentostatin DC7C9ED Pentostatin Amelanotic melanoma (Cell Line: M14) [3]
Dacarbazine + Pentostatin DCZSJLB Pentostatin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Picoplatin DCKVQKE Picoplatin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Picoplatin DC3U30K Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Dacarbazine + Fulvestrant DCD3J5E Fulvestrant Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Fulvestrant DCRVJ41 Fulvestrant Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Fulvestrant DCEBU71 Fulvestrant Glioma (Cell Line: SF-268) [3]
Dacarbazine + Fulvestrant DCDV0SJ Fulvestrant Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Hepzato DC0MM4Y Hepzato Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Hepzato DC4UVM8 Hepzato Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Dacarbazine + Hepzato DCTZQ2O Hepzato Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Dacarbazine + Ixabepilone DCRNWF6 Ixabepilone Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Ixabepilone DCRWB6Q Ixabepilone Amelanotic melanoma (Cell Line: M14) [3]
Dacarbazine + Ixabepilone DC5DPAN Ixabepilone Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Ixabepilone DCX8M0X Ixabepilone Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Ixabepilone DCPTAK1 Ixabepilone Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Dactinomycin DC0YESM Dactinomycin Adenocarcinoma (Cell Line: OVCAR3) [3]
Dacarbazine + Dactinomycin DCMR61Q Dactinomycin Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Dactinomycin DC0PE2Q Dactinomycin Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + Dactinomycin DCEQV8Y Dactinomycin Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Dactinomycin DCDBR05 Dactinomycin Adenocarcinoma (Cell Line: SW-620) [3]
Dacarbazine + Dactinomycin DC5NORO Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + Dactinomycin DC71GFA Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Dactinomycin DCGHDY1 Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Dactinomycin DCCVZOQ Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dacarbazine + Dactinomycin DCLPZ5P Dactinomycin Glioma (Cell Line: SF-268) [3]
Dacarbazine + Dactinomycin DC2AVEF Dactinomycin Glioma (Cell Line: SF-539) [3]
Dacarbazine + Dactinomycin DC0ZZQX Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dacarbazine + Dactinomycin DCH2OBE Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Dacarbazine + Dactinomycin DCXPODB Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Dactinomycin DCSRN6N Dactinomycin Lung adenocarcinoma (Cell Line: EKVX) [3]
Dacarbazine + Dactinomycin DCXD34X Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Dacarbazine + Dactinomycin DC7KJY6 Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Dactinomycin DC4918L Dactinomycin Melanoma (Cell Line: MALME-3M) [3]
Dacarbazine + Dactinomycin DCMB458 Dactinomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Dacarbazine + Dactinomycin DCHDYXO Dactinomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Dacarbazine + Dactinomycin DCEJ0V0 Dactinomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Dacarbazine + Dactinomycin DC1IVLW Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + DFN-15 DCGUWKH DFN-15 Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + DFN-15 DCET1CE DFN-15 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + DFN-15 DCB90KT DFN-15 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + DFN-15 DCJWLM2 DFN-15 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + DFN-15 DC99E1C DFN-15 Prostate carcinoma (Cell Line: PC-3) [3]
Dacarbazine + Lapatinib DCONUCV Lapatinib Adenocarcinoma (Cell Line: NCIH23) [3]
Dacarbazine + Lapatinib DCBPCIF Lapatinib Adenocarcinoma (Cell Line: SW-620) [3]
Dacarbazine + Lapatinib DC5MQGC Lapatinib Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Lapatinib DCHOMR9 Lapatinib Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Lapatinib DCVTWBH Lapatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Lapatinib DCV47KL Lapatinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Lapatinib DC7GYHU Lapatinib Amelanotic melanoma (Cell Line: M14) [3]
Dacarbazine + Lapatinib DC5ZLYQ Lapatinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Lapatinib DCBZ75X Lapatinib Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Lapatinib DCOHM0D Lapatinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Lapatinib DCPYPW4 Lapatinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dacarbazine + Lapatinib DCBFCH4 Lapatinib Glioma (Cell Line: SF-295) [3]
Dacarbazine + Lapatinib DCVBYCQ Lapatinib Glioma (Cell Line: SF-268) [3]
Dacarbazine + Lapatinib DCQKYJG Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dacarbazine + Lapatinib DCYBKQM Lapatinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + Lapatinib DCHD6O8 Lapatinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Lapatinib DCVAKD7 Lapatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + PMID28460551-Compound-2 DCTI1FK PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH23) [3]
Dacarbazine + PMID28460551-Compound-2 DCJNJOL PMID28460551-Compound-2 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + PMID28460551-Compound-2 DCK89U5 PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + PMID28460551-Compound-2 DCIGA1J PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + PMID28460551-Compound-2 DC7GF4K PMID28460551-Compound-2 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + PMID28460551-Compound-2 DCVXDCM PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + PMID28460551-Compound-2 DCFUB75 PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Dacarbazine + PMID28460551-Compound-2 DCZTOYE PMID28460551-Compound-2 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Crizotinib DCVBZUV Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dacarbazine + Crizotinib DC5HKLR Crizotinib Glioma (Cell Line: SF-295) [3]
Dacarbazine + Crizotinib DCXE32D Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dacarbazine + Crizotinib DCRGP0C Crizotinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + Crizotinib DCD171U Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Crizotinib DCHVUDA Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Dacarbazine + Crizotinib DC1301X Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Crizotinib DC6YV5O Crizotinib Renal cell carcinoma (Cell Line: SN12C) [3]
Dacarbazine + Cyclophosphamide DC2O3AY Cyclophosphamide Adenocarcinoma (Cell Line: SW-620) [3]
Dacarbazine + Cyclophosphamide DCD593I Cyclophosphamide Chronic myelogenous leukemia (Cell Line: K-562) [3]
Dacarbazine + LIAROZOLE DCLHTKO LIAROZOLE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Methotrexate DCB81PD Methotrexate Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Methotrexate DC2Q7AJ Methotrexate Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Methotrexate DCPALH6 Methotrexate Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Dacarbazine + Isoniazid DCG60J0 Isoniazid Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + Isoniazid DCPBK5H Isoniazid High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Dacarbazine + Isoniazid DCJ8VFS Isoniazid Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Isoniazid DCP3VKW Isoniazid Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Isoniazid DCBC46Y Isoniazid Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Arsenic trioxide DC9C5W1 Arsenic trioxide Adenocarcinoma (Cell Line: DU-145) [3]
Dacarbazine + Vemurafenib DCMBBNW Vemurafenib Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Vemurafenib DCYGKN6 Vemurafenib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Vemurafenib DC2LEYC Vemurafenib Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Vemurafenib DCOSCZA Vemurafenib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Vemurafenib DCW0J9I Vemurafenib Glioma (Cell Line: SF-295) [3]
Dacarbazine + Vemurafenib DCN2DJ3 Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dacarbazine + Vemurafenib DCGKNBB Vemurafenib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Dacarbazine + Plicamycin DCBMLTU Plicamycin Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Plicamycin DCQMNR5 Plicamycin Adenocarcinoma (Cell Line: SW-620) [3]
Dacarbazine + Plicamycin DCKETFR Plicamycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Plicamycin DCD005P Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + Plicamycin DCKQ3SE Plicamycin Amelanotic melanoma (Cell Line: M14) [3]
Dacarbazine + Plicamycin DCXXCSW Plicamycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Plicamycin DCE4SLQ Plicamycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Dacarbazine + Plicamycin DCWWH9Z Plicamycin Glioma (Cell Line: SF-295) [3]
Dacarbazine + Plicamycin DCYX5HJ Plicamycin Glioma (Cell Line: SF-539) [3]
Dacarbazine + Plicamycin DCK8LI0 Plicamycin Melanoma (Cell Line: MALME-3M) [3]
Dacarbazine + Plicamycin DCAEXU1 Plicamycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Plicamycin DCCNC9T Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Nilotinib DCG9T13 Nilotinib Adenocarcinoma (Cell Line: NCIH23) [3]
Dacarbazine + Nilotinib DCJ29YG Nilotinib Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Nilotinib DCHKNGA Nilotinib Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Nilotinib DCPX6GC Nilotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Nilotinib DC9XJAN Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Nilotinib DC8WE67 Nilotinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Nilotinib DC4K3Y7 Nilotinib Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Nilotinib DCQU60M Nilotinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Nilotinib DCYVAZG Nilotinib Glioma (Cell Line: SF-268) [3]
Dacarbazine + Nilotinib DCP4H2J Nilotinib Glioma (Cell Line: SF-295) [3]
Dacarbazine + Nilotinib DCNBOLW Nilotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dacarbazine + Nilotinib DCJBE82 Nilotinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + Nilotinib DCD5F1K Nilotinib Malignant melanoma (Cell Line: UACC62) [3]
Dacarbazine + Thioguanine DCI1RJL Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Thioguanine DCVY9PV Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Thioguanine DC3YK7M Thioguanine Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Thioguanine DCVB9OC Thioguanine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Thioguanine DC8AF8G Thioguanine Glioma (Cell Line: SF-268) [3]
Dacarbazine + Thioguanine DCZ6ISJ Thioguanine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Dacarbazine + Thioguanine DCHUKBX Thioguanine Melanoma (Cell Line: SK-MEL-2) [3]
Dacarbazine + Thioguanine DCHLYVQ Thioguanine Renal cell carcinoma (Cell Line: SN12C) [3]
Dacarbazine + Triapine DCZY3A6 Triapine Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Dacarbazine + 10-hydroxycamptothecin DCWZIZX 10-hydroxycamptothecin Adenocarcinoma (Cell Line: OVCAR3) [3]
Dacarbazine + 10-hydroxycamptothecin DCOWB5D 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + 10-hydroxycamptothecin DCO6WKI 10-hydroxycamptothecin Glioma (Cell Line: SF-295) [3]
Dacarbazine + 10-hydroxycamptothecin DCWSBM9 10-hydroxycamptothecin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Topetecan DCBEQPY Topetecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Topetecan DCKS9IC Topetecan Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Topetecan DCMTM2L Topetecan Astrocytoma (Cell Line: U251) [3]
Dacarbazine + Topetecan DCVPRRZ Topetecan Glioma (Cell Line: SF-295) [3]
Dacarbazine + Topetecan DCPH0NC Topetecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Pralatrexate DC9G3I1 Pralatrexate Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Terameprocol DC6OGN0 Terameprocol Adenocarcinoma (Cell Line: HT29) [3]
Dacarbazine + Terameprocol DC3ALZB Terameprocol Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Terameprocol DCOH4WS Terameprocol Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + Terameprocol DCHZOS9 Terameprocol Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Terameprocol DC9JF62 Terameprocol Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Terameprocol DCAQ3KU Terameprocol Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Dacarbazine + SCH 727965 DCOUKFQ SCH 727965 Adenocarcinoma (Cell Line: NCIH23) [3]
Dacarbazine + SCH 727965 DCA81BJ SCH 727965 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + SCH 727965 DCQ2N7Y SCH 727965 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + SCH 727965 DCHM4PD SCH 727965 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + SCH 727965 DC1MAF0 SCH 727965 Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + SCH 727965 DCBAIPH SCH 727965 Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dacarbazine + SCH 727965 DCOW67D SCH 727965 Glioma (Cell Line: SF-295) [3]
Dacarbazine + SCH 727965 DCSSSKZ SCH 727965 Glioma (Cell Line: SF-268) [3]
Dacarbazine + SCH 727965 DCLZMEF SCH 727965 Malignant melanoma (Cell Line: UACC62) [3]
Dacarbazine + SCH 727965 DCZDFYL SCH 727965 Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + SCH 727965 DC3R6OP SCH 727965 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Docetaxel DC8TOX8 Docetaxel Adenocarcinoma (Cell Line: HT29) [3]
Dacarbazine + Docetaxel DCHE0CS Docetaxel Amelanotic melanoma (Cell Line: M14) [3]
Dacarbazine + Docetaxel DCF3G10 Docetaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Docetaxel DC920PD Docetaxel Melanoma (Cell Line: MALME-3M) [3]
Dacarbazine + Docetaxel DCFXW50 Docetaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Dacarbazine + Docetaxel DCL5XK7 Docetaxel Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Dacarbazine + Raloxifene DC3MACC Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Raloxifene DCUJHZT Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Raloxifene DCD2DXE Raloxifene Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Raloxifene DCSHZE8 Raloxifene Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + Bendamustine hydrochloride DC6Z6UB Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [3]
Dacarbazine + Bendamustine hydrochloride DCXYPQQ Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Bendamustine hydrochloride DCNNBG3 Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + Bendamustine hydrochloride DCP9CLU Bendamustine hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [3]
Dacarbazine + Bendamustine hydrochloride DCPV8UY Bendamustine hydrochloride Glioma (Cell Line: SF-268) [3]
Dacarbazine + Bendamustine hydrochloride DCPAPNK Bendamustine hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Dacarbazine + Bendamustine hydrochloride DCM33W2 Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Bendamustine hydrochloride DCHOSW9 Bendamustine hydrochloride Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Dacarbazine + Bendamustine hydrochloride DC2WFLZ Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [3]
Dacarbazine + Bendamustine hydrochloride DCH3V3M Bendamustine hydrochloride Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Bendamustine hydrochloride DCPJJF8 Bendamustine hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Sirolimus DCTFXJP Sirolimus Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Letrozole DCSXRG4 Letrozole Adenocarcinoma (Cell Line: SW-620) [3]
Dacarbazine + Letrozole DC8Q7XJ Letrozole Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Letrozole DC9ATT2 Letrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Letrozole DCIPRA1 Letrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + Letrozole DC3J5P4 Letrozole Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Letrozole DC9SUZU Letrozole Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Mitomycin DCI9L71 Mitomycin Adenocarcinoma (Cell Line: SW-620) [3]
Dacarbazine + Mitomycin DCJAUA1 Mitomycin Adenocarcinoma (Cell Line: HT29) [3]
Dacarbazine + Mitomycin DCFRPVD Mitomycin Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Mitomycin DC7XC34 Mitomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Mitomycin DCCMPVQ Mitomycin Glioma (Cell Line: SF-268) [3]
Dacarbazine + Mitomycin DCP0N3Y Mitomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Dacarbazine + Mitomycin DC619GZ Mitomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Mitomycin DCSKSF5 Mitomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + SY-1425 DCZVV6X SY-1425 Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + SY-1425 DC63T1C SY-1425 Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + SY-1425 DCG9M0P SY-1425 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + SY-1425 DCUX4W7 SY-1425 Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Dacarbazine + SY-1425 DCP60R3 SY-1425 Glioma (Cell Line: SF-539) [3]
Dacarbazine + SY-1425 DCQW3GW SY-1425 Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Dacarbazine + SY-1425 DC0XDBZ SY-1425 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Dacarbazine + Vincristine DCJ1ZIR Vincristine Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Vincristine DCPO0CF Vincristine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Vincristine DCQ7ESX Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + Vincristine DCW8CA2 Vincristine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Vincristine DCX39CA Vincristine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Vincristine DC5EE5S Vincristine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Vincristine DCYPJFB Vincristine Glioma (Cell Line: SF-295) [3]
Dacarbazine + Vincristine DC7SCZR Vincristine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Dacarbazine + Vincristine DC54IJ7 Vincristine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Arfolitixorin DC3J0XM Arfolitixorin Adenocarcinoma (Cell Line: OVCAR3) [3]
Dacarbazine + Arfolitixorin DCKYLQ0 Arfolitixorin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Arfolitixorin DCZHM7A Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Arfolitixorin DC17DYA Arfolitixorin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Dacarbazine + Arfolitixorin DCPNPFJ Arfolitixorin Glioma (Cell Line: SF-268) [3]
Dacarbazine + Arfolitixorin DC6GHFW Arfolitixorin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Dacarbazine + Arfolitixorin DC9GYOL Arfolitixorin Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Arfolitixorin DCCDQ6S Arfolitixorin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Altretamine DCSRCL6 Altretamine Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dacarbazine + Altretamine DC8N2AJ Altretamine Glioma (Cell Line: SF-295) [3]
Dacarbazine + Altretamine DCJML8I Altretamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + TEM DCZKVSH TEM Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + TEM DCDDMZD TEM Prostate carcinoma (Cell Line: PC-3) [3]
Dacarbazine + JNK-IN-8 DC29JEH JNK-IN-8 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + JNK-IN-8 DCD13CQ JNK-IN-8 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + JNK-IN-8 DCRQDCI JNK-IN-8 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dacarbazine + JNK-IN-8 DC8CL5B JNK-IN-8 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Idarubicin DCRIO9D Idarubicin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Idarubicin DC02IWX Idarubicin Glioblastoma? (Cell Line: T98G) [3]
Dacarbazine + Idarubicin DCC3LKH Idarubicin Glioma (Cell Line: SF-268) [3]
Dacarbazine + Idarubicin DC0ISQV Idarubicin Glioma (Cell Line: SF-295) [3]
Dacarbazine + Idarubicin DCYPK0H Idarubicin Melanoma (Cell Line: UACC-257) [3]
Dacarbazine + Idarubicin DCBXNJ3 Idarubicin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Imatinib DCOZP5K Imatinib Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + Imatinib DCACFOU Imatinib Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Imatinib DCAJ562 Imatinib Adenocarcinoma (Cell Line: SW-620) [3]
Dacarbazine + Imatinib DCZ09SE Imatinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Imatinib DCJ5KRD Imatinib Amelanotic melanoma (Cell Line: M14) [3]
Dacarbazine + Imatinib DC0XOD5 Imatinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Imatinib DC9OEFF Imatinib Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Imatinib DCBLRNM Imatinib Glioma (Cell Line: SF-295) [3]
Dacarbazine + Imatinib DC9YKWC Imatinib Glioma (Cell Line: SF-268) [3]
Dacarbazine + Imatinib DCHQAZR Imatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Dacarbazine + Imatinib DCJB1QL Imatinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + Imatinib DCXZ207 Imatinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Imatinib DCZS4R8 Imatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Dacarbazine + Imatinib DC8DN8V Imatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Bleomycin DC24OFM Bleomycin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Bleomycin DCFZ3K6 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Bleomycin DCSAS1E Bleomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Bleomycin DCF5LZ6 Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Dacarbazine + Bleomycin DC78WCC Bleomycin Melanoma (Cell Line: SK-MEL-2) [3]
Dacarbazine + Bleomycin DCFUBW8 Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Bortezomib DCDCVYP Bortezomib Adenocarcinoma (Cell Line: A549) [3]
Dacarbazine + Bortezomib DCNZA6D Bortezomib Adenocarcinoma (Cell Line: NCIH23) [3]
Dacarbazine + Bortezomib DC728RN Bortezomib Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Bortezomib DC0L0KP Bortezomib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Bortezomib DCIVMIV Bortezomib Astrocytoma (Cell Line: U251) [3]
Dacarbazine + Bortezomib DCH4BJU Bortezomib Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Bortezomib DC3VZ50 Bortezomib Glioma (Cell Line: SF-295) [3]
Dacarbazine + Bortezomib DCM4D58 Bortezomib Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Bortezomib DCD9G8Y Bortezomib Melanoma (Cell Line: UACC-257) [3]
Dacarbazine + Bortezomib DC4QKBZ Bortezomib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Dacarbazine + Bortezomib DCL3KMS Bortezomib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Valrubicin DCA79GG Valrubicin Adenocarcinoma (Cell Line: SW-620) [3]
Dacarbazine + Valrubicin DCRYZMN Valrubicin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Valrubicin DCV88K1 Valrubicin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Valrubicin DC9VSKP Valrubicin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Dacarbazine + Valrubicin DCCODSJ Valrubicin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Valrubicin DCRIEA7 Valrubicin Melanoma (Cell Line: UACC-257) [3]
Dacarbazine + Topotecan DCJA7ZD Topotecan Adenocarcinoma (Cell Line: OVCAR3) [3]
Dacarbazine + Topotecan DCLDNDY Topotecan Adenocarcinoma (Cell Line: HT29) [3]
Dacarbazine + Topotecan DC3UP3T Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + Topotecan DC9TE6J Topotecan Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Topotecan DCO4LVH Topotecan Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Dacarbazine + Topotecan DCZPJUH Topotecan Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Topotecan DCILXJH Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Dacarbazine + Topotecan DCO7JZH Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Dacarbazine + Topotecan DCXYK85 Topotecan Glioma (Cell Line: SF-268) [3]
Dacarbazine + Topotecan DCJK9CT Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Dacarbazine + Topotecan DCC1LYL Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dacarbazine + Topotecan DCQMRJB Topotecan Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Dacarbazine + Topotecan DCWTMWY Topotecan Lung adenocarcinoma (Cell Line: EKVX) [3]
Dacarbazine + Topotecan DCX2TTK Topotecan Melanoma (Cell Line: UACC-257) [3]
Dacarbazine + Topotecan DC2CK9A Topotecan Melanoma (Cell Line: MALME-3M) [3]
Dacarbazine + Topotecan DCSZ3BY Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Dacarbazine + Topotecan DCIVB3M Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Dacarbazine + Topotecan DCBSUWB Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Cisplatin DCDAK6H Cisplatin Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Cisplatin DCW41HM Cisplatin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Cisplatin DC3LWL4 Cisplatin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Dacarbazine + Cisplatin DC0HJRJ Cisplatin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dacarbazine + Cisplatin DCZ2GMY Cisplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Chlorambucil DCD41DO Chlorambucil Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Chlorambucil DCMI0PH Chlorambucil Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Chlorambucil DCXQ7DS Chlorambucil Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Chlorambucil DC5TCGP Chlorambucil Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Chlorambucil DC6TWHU Chlorambucil Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Chlorambucil DCQBTV5 Chlorambucil Glioma (Cell Line: SF-295) [3]
Dacarbazine + Chlorambucil DCRSOT2 Chlorambucil Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + Chlorambucil DCTKD5H Chlorambucil Melanoma (Cell Line: UACC-257) [3]
Dacarbazine + Chlorambucil DC0XGTE Chlorambucil Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Dacarbazine + Sorafenib DC121B9 Sorafenib Adenocarcinoma (Cell Line: HT29) [3]
Dacarbazine + Sorafenib DC7KPL1 Sorafenib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Sorafenib DCSFNPL Sorafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dacarbazine + Sorafenib DC9K1DG Sorafenib Glioma (Cell Line: SF-295) [3]
Dacarbazine + Sorafenib DC43SEZ Sorafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dacarbazine + Sorafenib DCPW4SU Sorafenib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + ER819762 DC55JWU ER819762 Adenocarcinoma (Cell Line: OVCAR3) [3]
Dacarbazine + ER819762 DC0TU4K ER819762 Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + ER819762 DC13SG2 ER819762 Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + ER819762 DC511QI ER819762 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + ER819762 DCSJBGF ER819762 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + ER819762 DCDBIR7 ER819762 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + ER819762 DCWXD2Z ER819762 Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + ER819762 DCNIGPI ER819762 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + ER819762 DCUQIOF ER819762 Glioma (Cell Line: SF-295) [3]
Dacarbazine + ER819762 DCHOFNA ER819762 Glioma (Cell Line: SF-268) [3]
Dacarbazine + ER819762 DCXUD63 ER819762 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Dacarbazine + ER819762 DC76J9W ER819762 Lung adenocarcinoma (Cell Line: HOP-62) [3]
Dacarbazine + ER819762 DCU8NGR ER819762 Melanoma (Cell Line: UACC-257) [3]
Dacarbazine + ER819762 DCBFT7X ER819762 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Dacarbazine + ER819762 DCR5DCZ ER819762 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Romidepsin DCBHO58 Romidepsin Adenocarcinoma (Cell Line: A549) [3]
Dacarbazine + Romidepsin DCJ8DJO Romidepsin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Romidepsin DC1INYN Romidepsin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Romidepsin DCJI44M Romidepsin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Dacarbazine + Romidepsin DCHYN2U Romidepsin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dacarbazine + Romidepsin DC9C9NT Romidepsin Glioblastoma (Cell Line: SNB-75) [3]
Dacarbazine + Romidepsin DC7WSEP Romidepsin Glioma (Cell Line: SF-268) [3]
Dacarbazine + Romidepsin DCC800G Romidepsin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Dacarbazine + Romidepsin DC8FXOF Romidepsin Lung adenocarcinoma (Cell Line: EKVX) [3]
Dacarbazine + Romidepsin DC2SAYU Romidepsin Melanoma (Cell Line: MALME-3M) [3]
Dacarbazine + Azacitidine DCF4233 Azacitidine Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Azacitidine DCU2T7P Azacitidine Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Dacarbazine + Azacitidine DCEJIRJ Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Azacitidine DCJBE8O Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Pomalidomide DCVFAEC Pomalidomide Adenocarcinoma (Cell Line: OVCAR3) [3]
Dacarbazine + Pomalidomide DCQN1R8 Pomalidomide Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + Pomalidomide DCV3DR9 Pomalidomide Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Pomalidomide DCYOO9G Pomalidomide Amelanotic melanoma (Cell Line: M14) [3]
Dacarbazine + Pomalidomide DC82U5Z Pomalidomide Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Pomalidomide DCZIREI Pomalidomide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Pomalidomide DCVGH9I Pomalidomide Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Pomalidomide DC2JPD6 Pomalidomide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Dacarbazine + Pomalidomide DCOLXFO Pomalidomide Glioblastoma (Cell Line: SNB-75) [3]
Dacarbazine + Pomalidomide DCJEP9E Pomalidomide Glioma (Cell Line: SF-295) [3]
Dacarbazine + Pomalidomide DC6O317 Pomalidomide High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Dacarbazine + Pomalidomide DCL9STY Pomalidomide Lung adenocarcinoma (Cell Line: EKVX) [3]
Dacarbazine + Pomalidomide DCLK467 Pomalidomide Malignant melanoma (Cell Line: UACC62) [3]
Dacarbazine + Pomalidomide DCLUQEH Pomalidomide Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Pomalidomide DC4DQYS Pomalidomide Renal cell carcinoma (Cell Line: SN12C) [3]
Dacarbazine + Vinflunine DCHOMMW Vinflunine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Mercaptopurine DC7RRB2 Mercaptopurine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Mercaptopurine DCZN6XX Mercaptopurine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Mercaptopurine DCDWL27 Mercaptopurine Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Mercaptopurine DCJPO9R Mercaptopurine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Mepacrine DCSH27S Mepacrine Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Dacarbazine + Mepacrine DC3ARZ4 Mepacrine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Fludarabine DCZVHAE Fludarabine Glioma (Cell Line: SF-268) [3]
Dacarbazine + Fludarabine DC8H3RO Fludarabine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Fludarabine DCGD7TN Fludarabine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + FORMESTANE DCBHHEL FORMESTANE Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + FORMESTANE DCF1W2X FORMESTANE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + FORMESTANE DC5LECO FORMESTANE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + FORMESTANE DC7807B FORMESTANE Glioma (Cell Line: SF-268) [3]
Dacarbazine + Aminolevulinic Acid Hydrochloride DCRXU6F Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: DU-145) [3]
Dacarbazine + Aminolevulinic Acid Hydrochloride DCQO9C9 Aminolevulinic Acid Hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dacarbazine + Aminolevulinic Acid Hydrochloride DC0TZAB Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Aminolevulinic Acid Hydrochloride DCXE0IH Aminolevulinic Acid Hydrochloride Glioblastoma (Cell Line: SNB-75) [3]
Dacarbazine + Aminolevulinic Acid Hydrochloride DCRLXLH Aminolevulinic Acid Hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Aminolevulinic Acid Hydrochloride DCT90ZX Aminolevulinic Acid Hydrochloride Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Estramustine DCEG185 Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + Estramustine DCRPCWB Estramustine Amelanotic melanoma (Cell Line: M14) [3]
Dacarbazine + Estramustine DCJOZSS Estramustine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Dacarbazine + Estramustine DCLKTXP Estramustine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Digitoxin DCUJADG Digitoxin Glioma (Cell Line: SF-539) [3]
Dacarbazine + Digitoxin DCWGACP Digitoxin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Busulfan DCVB4NL Busulfan Glioma (Cell Line: SF-539) [3]
Dacarbazine + Busulfan DCF9IX2 Busulfan Glioma (Cell Line: SF-268) [3]
Dacarbazine + Busulfan DCIVUPG Busulfan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Dasatinib DCR0L77 Dasatinib Adenocarcinoma (Cell Line: NCIH23) [3]
Dacarbazine + Dasatinib DCL0GMY Dasatinib Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + Dasatinib DC9PVSV Dasatinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Dasatinib DCJ9JO4 Dasatinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Dasatinib DCC4KKJ Dasatinib Astrocytoma (Cell Line: SNB-19) [3]
Dacarbazine + Dasatinib DCXCQT1 Dasatinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Dasatinib DCY3C1J Dasatinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Dacarbazine + Dasatinib DCHEV1I Dasatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Dasatinib DCHUSLQ Dasatinib Glioma (Cell Line: SF-539) [3]
Dacarbazine + Dasatinib DC987D4 Dasatinib Malignant melanoma (Cell Line: UACC62) [3]
Dacarbazine + Fulvestrant DCMLU26 Fulvestrant Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Hepzato DCN6ELJ Hepzato Invasive ductal carcinoma (Cell Line: T-47D) [5]
Dacarbazine + Dactinomycin DCQTI61 Dactinomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Dacarbazine + Dactinomycin DC9WCQQ Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [5]
Dacarbazine + Dactinomycin DC4CSMW Dactinomycin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Dactinomycin DC1LJR5 Dactinomycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dacarbazine + PMID28460551-Compound-2 DCLU101 PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [5]
Dacarbazine + PMID28460551-Compound-2 DCZ1TVK PMID28460551-Compound-2 Carcinoma (Cell Line: MCF7) [5]
Dacarbazine + PMID28460551-Compound-2 DC78RV3 PMID28460551-Compound-2 Colon carcinoma (Cell Line: KM12) [5]
Dacarbazine + PMID28460551-Compound-2 DC2DBAO PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Cyclophosphamide DCN5G3C Cyclophosphamide Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Isoniazid DCYUWMA Isoniazid Colon carcinoma (Cell Line: KM12) [5]
Dacarbazine + Plicamycin DCR4MIM Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Plicamycin DC5LFK0 Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dacarbazine + Nilotinib DCWUY2H Nilotinib Colon adenocarcinoma (Cell Line: COLO 205) [5]
Dacarbazine + Thioguanine DC767LE Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Dacarbazine + Thioguanine DC32SV2 Thioguanine Carcinoma (Cell Line: RXF 393) [5]
Dacarbazine + Thioguanine DCFJHN5 Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [5]
Dacarbazine + Terameprocol DCJQCW2 Terameprocol Colon carcinoma (Cell Line: KM12) [5]
Dacarbazine + Sirolimus DCSTZZE Sirolimus Colon adenocarcinoma (Cell Line: COLO 205) [5]
Dacarbazine + Letrozole DCK1QDY Letrozole Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dacarbazine + Mitomycin DCNLR2P Mitomycin Carcinoma (Cell Line: RXF 393) [5]
Dacarbazine + Mitomycin DCF6GX5 Mitomycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dacarbazine + Mitomycin DC8UJDC Mitomycin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Vincristine DCXV6UL Vincristine Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Arfolitixorin DCNQTC3 Arfolitixorin Carcinoma (Cell Line: RXF 393) [5]
Dacarbazine + Arfolitixorin DCGBQZN Arfolitixorin Colon adenocarcinoma (Cell Line: COLO 205) [5]
Dacarbazine + Arfolitixorin DCEW8IL Arfolitixorin Invasive ductal carcinoma (Cell Line: T-47D) [5]
Dacarbazine + Altretamine DCSMQV2 Altretamine Colon carcinoma (Cell Line: KM12) [5]
Dacarbazine + Imatinib DC8NZZY Imatinib Carcinoma (Cell Line: MCF7) [5]
Dacarbazine + Bleomycin DCOH6WD Bleomycin Carcinoma (Cell Line: MCF7) [5]
Dacarbazine + Bleomycin DCA9FVR Bleomycin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Bortezomib DCQBXBG Bortezomib Colon adenocarcinoma (Cell Line: COLO 205) [5]
Dacarbazine + Valrubicin DC2S5ZO Valrubicin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dacarbazine + Topotecan DCYT5IS Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dacarbazine + ER819762 DCDNXHJ ER819762 Colon carcinoma (Cell Line: KM12) [5]
Dacarbazine + Romidepsin DCX4ZA6 Romidepsin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Pomalidomide DCC250F Pomalidomide Colon carcinoma (Cell Line: KM12) [5]
Dacarbazine + Pomalidomide DCY3692 Pomalidomide Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dacarbazine + Mepacrine DCTJKER Mepacrine Colon carcinoma (Cell Line: KM12) [5]
Dacarbazine + FORMESTANE DCNGJ88 FORMESTANE Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dacarbazine + Aminolevulinic Acid Hydrochloride DCFHJYG Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Dasatinib DCAU19Q Dasatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Dacarbazine + Oblimersen DCQFE08 Oblimersen Melanoma (Cell Line: .) [6]
Dexrazoxane + Dacarbazine DCDM3N4 Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dexrazoxane + Dacarbazine DC2MXH6 Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dexrazoxane + Dacarbazine DCLYG85 Dexrazoxane Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Dexrazoxane + Dacarbazine DCNN62A Dexrazoxane Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dexrazoxane + Dacarbazine DCSLDCT Dexrazoxane Glioma (Cell Line: SF-268) [3]
Dexrazoxane + Dacarbazine DCL6CYB Dexrazoxane Renal cell carcinoma (Cell Line: SN12C) [3]
Dexrazoxane + Dacarbazine DC9419N Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [5]
Dexrazoxane + Dacarbazine DCVFRJO Dexrazoxane Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Epirubicin + Dacarbazine DCWLZVN Epirubicin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Epirubicin + Dacarbazine DCCTSYB Epirubicin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Epirubicin + Dacarbazine DCC5KYA Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Epirubicin + Dacarbazine DCJ7EDC Epirubicin Glioma (Cell Line: SF-295) [3]
Epirubicin + Dacarbazine DCE8M4I Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Epirubicin + Dacarbazine DCWTWSB Epirubicin Renal cell carcinoma (Cell Line: SN12C) [3]
Epirubicin + Dacarbazine DCR1AT8 Epirubicin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Epirubicin + Dacarbazine DCO4FUQ Epirubicin Invasive ductal carcinoma (Cell Line: T-47D) [5]
Epirubicin + Dacarbazine DCH2ZSS Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Epirubicin + Dacarbazine DCS89RG Epirubicin Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Epirubicin + Dacarbazine DC2VB5X Epirubicin Amelanotic melanoma (Cell Line: M14) [4]
Epirubicin + Dacarbazine DC9JR94 Epirubicin Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Epirubicin + Dacarbazine DC0HHDE Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Epirubicin + Dacarbazine DC36PYE Epirubicin Lung adenocarcinoma (Cell Line: HOP-62) [4]
Epirubicin + Dacarbazine DCF7527 Epirubicin Malignant melanoma (Cell Line: UACC62) [4]
Epirubicin + Dacarbazine DCR9JRU Epirubicin Melanoma (Cell Line: SK-MEL-2) [4]
Gefitinib + Dacarbazine DC926OV Gefitinib Amelanotic melanoma (Cell Line: M14) [3]
Gefitinib + Dacarbazine DCC0ITW Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Gefitinib + Dacarbazine DCC5GAT Gefitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Gefitinib + Dacarbazine DC8P9OX Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Gefitinib + Dacarbazine DCR5SK9 Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Gefitinib + Dacarbazine DCFOW61 Gefitinib Lung adenocarcinoma (Cell Line: EKVX) [3]
Gefitinib + Dacarbazine DC7B4JW Gefitinib Malignant melanoma (Cell Line: UACC62) [3]
Gefitinib + Dacarbazine DCU9A3U Gefitinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Gefitinib + Dacarbazine DCDP5LO Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Gefitinib + Dacarbazine DCFKQ5B Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Indazole derivative 5 + Dacarbazine DCKAAPE Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Indazole derivative 5 + Dacarbazine DCYF0GR Indazole derivative 5 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Indazole derivative 5 + Dacarbazine DC7GFS4 Indazole derivative 5 Astrocytoma (Cell Line: SNB-19) [3]
Indazole derivative 5 + Dacarbazine DCEM3B5 Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Indazole derivative 5 + Dacarbazine DC6ELHZ Indazole derivative 5 Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Indazole derivative 5 + Dacarbazine DC8UWPL Indazole derivative 5 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Indazole derivative 5 + Dacarbazine DC0X2JR Indazole derivative 5 Carcinoma (Cell Line: RXF 393) [5]
Indazole derivative 5 + Dacarbazine DCHTB3L Indazole derivative 5 Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Indazole derivative 5 + Dacarbazine DCZWCCU Indazole derivative 5 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Indazole derivative 5 + Dacarbazine DCGBNKW Indazole derivative 5 Amelanotic melanoma (Cell Line: M14) [4]
Indazole derivative 5 + Dacarbazine DCXQABI Indazole derivative 5 Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Indazole derivative 5 + Dacarbazine DCHCWC9 Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Indazole derivative 5 + Dacarbazine DCBA01I Indazole derivative 5 Lung adenocarcinoma (Cell Line: HOP-62) [4]
Indazole derivative 5 + Dacarbazine DCGBKD3 Indazole derivative 5 Malignant melanoma (Cell Line: LOX IMVI) [4]
Indazole derivative 5 + Dacarbazine DC8UH00 Indazole derivative 5 Melanoma (Cell Line: SK-MEL-2) [4]
Lenalidomide + Dacarbazine DCM8S9K Lenalidomide Invasive ductal carcinoma (Cell Line: T-47D) [5]
Lenalidomide + Dacarbazine DC1QJGR Lenalidomide Amelanotic melanoma (Cell Line: M14) [4]
Raloxifene + Dacarbazine DC56KE5 Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Raloxifene + Dacarbazine DCRDW8Z Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Raloxifene + Dacarbazine DC58BZV Raloxifene Chronic myelogenous leukemia (Cell Line: K-562) [3]
Raloxifene + Dacarbazine DCX2F4M Raloxifene Glioma (Cell Line: SF-268) [3]
Raloxifene + Dacarbazine DCOKG4G Raloxifene Glioma (Cell Line: SF-539) [3]
Raloxifene + Dacarbazine DC0CSRM Raloxifene Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Raloxifene + Dacarbazine DCAZSPV Raloxifene Colon adenocarcinoma (Cell Line: COLO 205) [5]
Raloxifene + Dacarbazine DCGSX4G Raloxifene Adenocarcinoma (Cell Line: SW-620) [4]
Raloxifene + Dacarbazine DC9JOT9 Raloxifene Adenocarcinoma (Cell Line: HCT-15) [4]
Raloxifene + Dacarbazine DCSC5TV Raloxifene Adenocarcinoma (Cell Line: HCC-2998) [4]
Raloxifene + Dacarbazine DCDSB2G Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Raloxifene + Dacarbazine DC89T1V Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Raloxifene + Dacarbazine DC0YTEI Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Raloxifene + Dacarbazine DC5C6L8 Raloxifene Melanoma (Cell Line: SK-MEL-2) [4]
Raloxifene + Dacarbazine DCI9COQ Raloxifene Melanoma (Cell Line: UACC-257) [4]
Ruxolitinib + Dacarbazine DC0S84M Ruxolitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Ruxolitinib + Dacarbazine DCVU9NV Ruxolitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Ruxolitinib + Dacarbazine DCQHXAE Ruxolitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Ruxolitinib + Dacarbazine DC5QQ81 Ruxolitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Ruxolitinib + Dacarbazine DC4NRJC Ruxolitinib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Ruxolitinib + Dacarbazine DC7TMPC Ruxolitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Ruxolitinib + Dacarbazine DCTTXKS Ruxolitinib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Ruxolitinib + Dacarbazine DC0PK6Q Ruxolitinib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Ruxolitinib + Dacarbazine DCEF2E7 Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Ruxolitinib + Dacarbazine DCDNLJF Ruxolitinib Adenocarcinoma (Cell Line: HCT-15) [4]
Ruxolitinib + Dacarbazine DCW6KG3 Ruxolitinib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Ruxolitinib + Dacarbazine DCE8NXU Ruxolitinib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Ruxolitinib + Dacarbazine DCB6CFH Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Ruxolitinib + Dacarbazine DCZ9YTF Ruxolitinib Malignant melanoma (Cell Line: LOX IMVI) [4]
Ruxolitinib + Dacarbazine DCUNPKN Ruxolitinib Melanoma (Cell Line: SK-MEL-2) [4]
Ruxolitinib + Dacarbazine DCXFF18 Ruxolitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Uracil mustard + Dacarbazine DCHCIFA Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Dacarbazine DCFQZ6O Uracil mustard Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Dacarbazine DCM75OP Uracil mustard Glioma (Cell Line: SF-268) [3]
Uracil mustard + Dacarbazine DCMHXKW Uracil mustard Glioma (Cell Line: SF-295) [3]
Uracil mustard + Dacarbazine DCIYXU0 Uracil mustard Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Dacarbazine DCOG94U Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Uracil mustard + Dacarbazine DC2MUIH Uracil mustard Lung adenocarcinoma (Cell Line: EKVX) [4]
Uracil mustard + Dacarbazine DCQYK7O Uracil mustard Melanoma (Cell Line: SK-MEL-2) [4]
Uracil mustard + Dacarbazine DCB9CYN Uracil mustard Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Vandetanib + Dacarbazine DCABH4F Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Vandetanib + Dacarbazine DCBAVHJ Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Vandetanib + Dacarbazine DCK05L6 Vandetanib Adenocarcinoma (Cell Line: SW-620) [4]
Vandetanib + Dacarbazine DCR42HV Vandetanib Adenocarcinoma (Cell Line: HCT-15) [4]
Vandetanib + Dacarbazine DC25MHC Vandetanib Adenocarcinoma (Cell Line: HCC-2998) [4]
Vandetanib + Dacarbazine DCO8K02 Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vandetanib + Dacarbazine DCX6OCA Vandetanib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Vandetanib + Dacarbazine DCUW97J Vandetanib Amelanotic melanoma (Cell Line: M14) [4]
Vandetanib + Dacarbazine DCXU8DI Vandetanib Anaplastic large cell lymphoma (Cell Line: SR) [4]
Vandetanib + Dacarbazine DCQY3VV Vandetanib Astrocytoma (Cell Line: SNB-19) [4]
Vandetanib + Dacarbazine DC6KY4V Vandetanib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vandetanib + Dacarbazine DC2O6XD Vandetanib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vandetanib + Dacarbazine DCT3Q09 Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Vandetanib + Dacarbazine DCD4HFJ Vandetanib Glioma (Cell Line: SF-295) [4]
Vandetanib + Dacarbazine DCVZ15S Vandetanib Glioma (Cell Line: SF-268) [4]
Vandetanib + Dacarbazine DCPA6IV Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Vandetanib + Dacarbazine DCZO1DM Vandetanib Malignant melanoma (Cell Line: LOX IMVI) [4]
Vandetanib + Dacarbazine DC5ZSPW Vandetanib Melanoma (Cell Line: SK-MEL-2) [4]
Vandetanib + Dacarbazine DC1K9J6 Vandetanib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Vandetanib + Dacarbazine DCLKD0G Vandetanib Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Vandetanib + Dacarbazine DCPICCI Vandetanib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vandetanib + Dacarbazine DCOYBAI Vandetanib Renal cell carcinoma (Cell Line: SN12C) [4]
Vemurafenib + Dacarbazine DCR89Q5 Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Vemurafenib + Dacarbazine DCM1TTK Vemurafenib Carcinoma (Cell Line: MCF7) [5]
Vemurafenib + Dacarbazine DC0A2KM Vemurafenib Colon adenocarcinoma (Cell Line: COLO 205) [5]
Vemurafenib + Dacarbazine DC7IVWS Vemurafenib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Vemurafenib + Dacarbazine DCQNMCX Vemurafenib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vemurafenib + Dacarbazine DCT7CY8 Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Vemurafenib + Dacarbazine DC1IWZQ Vemurafenib Adenocarcinoma (Cell Line: OVCAR3) [4]
Vemurafenib + Dacarbazine DCUS1SA Vemurafenib Adenocarcinoma (Cell Line: HCT-15) [4]
Vemurafenib + Dacarbazine DC05QQO Vemurafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vemurafenib + Dacarbazine DCCCS63 Vemurafenib Amelanotic melanoma (Cell Line: M14) [4]
Vemurafenib + Dacarbazine DC36LWS Vemurafenib Chronic myelogenous leukemia (Cell Line: K-562) [4]
Vemurafenib + Dacarbazine DCOUX7J Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vemurafenib + Dacarbazine DC2VNAL Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vemurafenib + Dacarbazine DC9LLTD Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Vemurafenib + Dacarbazine DCGURRG Vemurafenib Glioma (Cell Line: SF-295) [4]
Vemurafenib + Dacarbazine DCBNDYL Vemurafenib Glioma (Cell Line: SF-268) [4]
Vemurafenib + Dacarbazine DCHO2UV Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Vemurafenib + Dacarbazine DC1VBZM Vemurafenib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Vemurafenib + Dacarbazine DCTJ919 Vemurafenib Malignant melanoma (Cell Line: UACC62) [4]
Vemurafenib + Dacarbazine DC3A3M2 Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [4]
Vemurafenib + Dacarbazine DCLKA7T Vemurafenib Melanoma (Cell Line: UACC-257) [4]
Vemurafenib + Dacarbazine DCTWX7M Vemurafenib Melanoma (Cell Line: SK-MEL-2) [4]
Vemurafenib + Dacarbazine DCQLPX0 Vemurafenib Melanoma (Cell Line: MALME-3M) [4]
Vemurafenib + Dacarbazine DCOW5VF Vemurafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Vemurafenib + Dacarbazine DCR8L8N Vemurafenib Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Vemurafenib + Dacarbazine DCWAQTC Vemurafenib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vismodegib + Dacarbazine DCV2VIA Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Vismodegib + Dacarbazine DC3XAYX Vismodegib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Vismodegib + Dacarbazine DCE4NUQ Vismodegib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Vismodegib + Dacarbazine DCT4EJR Vismodegib Amelanotic melanoma (Cell Line: M14) [4]
Vismodegib + Dacarbazine DC3THBN Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vismodegib + Dacarbazine DCVKDT0 Vismodegib Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Vismodegib + Dacarbazine DCTSAHK Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Vismodegib + Dacarbazine DCGAI45 Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Vismodegib + Dacarbazine DCWQXDO Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Vismodegib + Dacarbazine DC8UAGZ Vismodegib Lung adenocarcinoma (Cell Line: HOP-62) [4]
Vismodegib + Dacarbazine DCKVFKJ Vismodegib Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Vismodegib + Dacarbazine DC42FR3 Vismodegib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Vismodegib + Dacarbazine DCWY7OQ Vismodegib Papillary renal cell carcinoma (Cell Line: ACHN) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 680 DrugCom(s)

References

1 Dacarbazine FDA Label
2 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 075259.
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
5 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
6 Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.